Stay up to date on recent advances in oncology nursing and patient care.
Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences
Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses
FDA Approves Imlunestrant in ESR1+ HR+, HER2- Metastatic Breast Cancer
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
Structure to Safety: A Nurse's Guide to Safe ADC Care
A Nurse’s Overview of First-Line Treatment for HR+ Metastatic Breast Cancer
The Reality of VTE: How to Best Address in Cancer Care
AI Decision Support Tools Serve as Copilots in Cancer Care
Toxicity Monitoring, Management Crucial for Tarlatamab in ES-SCLC
Cancer Drug Repository Network Yields $18M in Patient Savings
